Orthobiologics market size is to grow by USD 2,638.44 million from 2022 to 2027; 41% of the market growth to originate from North America

NEW YORK, June 13, 2023 /PRNewswire/ — The Orthobiologics market size is expected to grow by USD 2,638.44 million from 2022 to 2027, progressing at a CAGR of 7.88% as per the latest Technavio market research report. North America is estimated to account for 41% of the market’s overall growth. North America dominated the market and is expected to maintain its position during the projection period due to the presence of a well-established healthcare system that provides high-quality orthobiologics. Obesity and an increase in the prevalence of arthritis have increased the demand for minimally invasive procedures such as bone grafting. The increase in sports injuries across North America is also a major factor driving the market. For more insights on the market share of various regions- Download sample report in MINUTES

What’s New?

• Special coverage on the Russia–Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints – Strong/Active/Niche/Trivial – Buy the Report!

Orthobiologics market: Increasing prevalence of orthopedic disorders to drive growth

• The increasing prevalence of orthopedic disorders coupled with an aging population is a key factor in the growth of the market. 
• Limited physical activity and eating habits can negatively influence the body’s homeostasis. This issue worsens with age, putting most persons aged 60 and up vulnerable to orthopedic disorders such as arthritis.
• Osteoarthritis in people of this age group can affect the joints and stress the knees, hips, and lower spine. Sophisticated treatment options and improved standards for healthcare have increased life expectancy, resulting in a further rise in the population of this age group. 
• For instance, in the US, approximately 70% of adults between 55 and 78 years suffer from osteoarthritis, which is expected to increase during the forecast period.

Orthobiologics market: The development of new products is a key trend

• The increase in the development of new products is a key trend in the market’s growth. 
• Many vendors offering orthobiologics such as SeaSpine Holdings Corp, and Bioventus LLC are focusing on developing new products to cater to customers with specific requirements. Furthermore, the rise in popularity of orthobiologics will drive market growth. 
• Orthobiologics therapy focuses on using the healing and rejuvenating properties of the body’s own cells for the repair of damaged tissues.
• Some of the innovative orthobiologics options which are helpful in the treatment of osteoarthritis include platelet-rich plasma (PRP), adipose tissue-derived mesenchymal stem cells (ADMSC), bone marrow concentrate (BMC), autologous chondrocyte implantation (ACI), and autologous conditioned serum.
• The availability of such products has resulted in preventing operative procedures such as knee arthroplasty for the treatment of osteoarthritis. 
• This, in turn, is anticipated to boost the growth of the orthobiologics market over the forecast period.

To know about more drivers, trends along with challenges – Download a sample now!

Some of the key Orthobiologics Market Players:

The global orthobiologics market has been witnessing high competition. The growing focus of vendors on developing highly innovative, safe, and effective devices for reliable results will increase the demand for a broad range of orthobiologics in the market, which increases the profit margins of vendors that are offering such products to end-users. Intense competition is observed in the global orthobiologics market, with the presence of Tier-1 and Tier-2 companies and small companies.

Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Bioventus LLC, Globus Medical Inc., Integra Lifesciences Holdings Corp., Johnson and Johnson, Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc, Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., Xtant Medical Inc., Zimmer Biomet Holdings Inc., and Arthrex Inc.

Orthobiologics Market: Segmentation Analysis

This market research report segments the orthobiologics market by application (spinal fusion, reconstructive surgery, trauma repair, and others), product (bone graft substitutes, viscosupplementation, and stem cells), and geography (North America, Europe, Asia, and Rest of World (ROW)).

The market share growth by the spinal fusion segment will be significant for overall market growth during the forecast period. Spinal fusion or spinal arthrodesis is a technique that permanently joins two or more vertebrae in the spine to increase stability, repair a deformity, or relieve discomfort. Patients with spinal disorders such as spinal abnormalities, spinal weakness or instability, and herniated discs can benefit from this therapy. As a result, orthobiologics improve the efficacy of spinal fusion surgeries by healing the targeted site. Such orthobiologic advantages in spinal fusion procedures will drive orthobiologic demand over the projection period.

Gain instant access to 17,000+ market research reports

Technavio’s SUBSCRIPTION platform

Related Reports:

• The Global Orthopedic Device Market size is estimated to grow by USD 12.11 billion between 2022 and 2027 accelerating at a CAGR of 3.85%. This orthopedic device market research report extensively covers market segmentation by application (spine, knee, hip, extremities, and others), product (orthopedic implants and support devices and orthobiologics), and geography (North America, Europe, Asia, and Rest of World (ROW)). The increase in the target population with orthopedic disorders, trauma, and sports injuries is notably driving the market growth. 
• The invisible orthodontics market share in North America is expected to increase to USD 1.05 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 12.1%. Furthermore, this report extensively covers the market segmentation by, product (clear aligners, ceramic braces, and lingual braces) and geography (US, Canada, and Mexico). The increasing number of dental conditions is one of the key drivers supporting North America’s market growth.

Table of Content

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global orthobiologics market 2017 – 2021
• Exhibit 18: Historic Market Size – Data Table on Global orthobiologics market 2017 – 2021 ($ million)

• 4.2 By Application Segment Analysis 2017 – 2021
• Exhibit 19: Historic Market Size – By Application Segment 2017 – 2021 ($ million)

• 4.3 By Product Segment Analysis 2017 – 2021
• Exhibit 20: Historic Market Size – By Product Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments 
• Exhibit 30: Chart on Application – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application – Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Spinal fusion – Market size and forecast 2022-2027
• Exhibit 34: Chart on Spinal fusion – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Spinal fusion – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Spinal fusion – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Spinal fusion – Year-over-year growth 2022-2027 (%)

• 6.4 Reconstructive surgery – Market size and forecast 2022-2027 
• Exhibit 38: Chart on Reconstructive surgery – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Reconstructive surgery – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Reconstructive surgery – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Reconstructive surgery – Year-over-year growth 2022-2027 (%)

• 6.5 Trauma repair – Market size and forecast 2022-2027
• Exhibit 42: Chart on Trauma repair – Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Trauma repair – Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Trauma repair – Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Trauma repair – Year-over-year growth 2022-2027 (%)

• 6.6 Others – Market size and forecast 2022-2027
• Exhibit 46: Chart on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)

• 6.7 Market opportunity by Application 
• Exhibit 50: Market opportunity by Application ($ million)

7 Market Segmentation by Product

• 7.1 Market segments 
• Exhibit 51: Chart on Product – Market share 2022-2027 (%)
• Exhibit 52: Data Table on Product – Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 53: Chart on Comparison by Product
• Exhibit 54: Data Table on Comparison by Product

• 7.3 Bone graft substitutes – Market size and forecast 2022-2027 
• Exhibit 55: Chart on Bone graft substitutes – Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Bone graft substitutes – Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Bone graft substitutes – Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Bone graft substitutes – Year-over-year growth 2022-2027 (%)

• 7.4 Viscosupplementation – Market size and forecast 2022-2027 
• Exhibit 59: Chart on Viscosupplementation – Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Viscosupplementation – Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Viscosupplementation – Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Viscosupplementation – Year-over-year growth 2022-2027 (%)

• 7.5 Stem cells – Market size and forecast 2022-2027
• Exhibit 63: Chart on Stem cells – Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Stem cells – Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Stem cells – Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Stem cells – Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Product 
• Exhibit 67: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 69: Chart on Market share by geography 2022-2027 (%)
• Exhibit 70: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027
• Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027
• Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027
• Exhibit 81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027
• Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 UK – Market size and forecast 2022-2027
• Exhibit 93: Chart on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on UK – Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on UK – Year-over-year growth 2022-2027 (%)

• 9.9 Germany – Market size and forecast 2022-2027
• Exhibit 97: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.10 China – Market size and forecast 2022-2027
• Exhibit 101: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.11 Canada – Market size and forecast 2022-2027
• Exhibit 105: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

11 Vendor Landscape

• 11.2 Vendor landscape 
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 Advanced Medical Solutions Group Plc
• Exhibit 116: Advanced Medical Solutions Group Plc – Overview
• Exhibit 117: Advanced Medical Solutions Group Plc – Business segments
• Exhibit 118: Advanced Medical Solutions Group Plc – Key offerings
• Exhibit 119: Advanced Medical Solutions Group Plc – Segment focus

• 12.4 Anika Therapeutics Inc. 
• Exhibit 120: Anika Therapeutics Inc. – Overview
• Exhibit 121: Anika Therapeutics Inc. – Product / Service
• Exhibit 122: Anika Therapeutics Inc. – Key offerings

• 12.5 Arthrex Inc. 
• Exhibit 123: Arthrex Inc. – Overview
• Exhibit 124: Arthrex Inc. – Product / Service
• Exhibit 125: Arthrex Inc. – Key offerings

• 12.6 Bioventus LLC 
• Exhibit 126: Bioventus LLC – Overview
• Exhibit 127: Bioventus LLC – Business segments
• Exhibit 128: Bioventus LLC – Key news
• Exhibit 129: Bioventus LLC – Key offerings
• Exhibit 130: Bioventus LLC – Segment focus

• 12.7 Globus Medical Inc. 
• Exhibit 131: Globus Medical Inc. – Overview
• Exhibit 132: Globus Medical Inc. – Product / Service
• Exhibit 133: Globus Medical Inc. – Key offerings

• 12.8 Johnson and Johnson 
• Exhibit 134: Johnson and Johnson – Overview
• Exhibit 135: Johnson and Johnson – Business segments
• Exhibit 136: Johnson and Johnson – Key news
• Exhibit 137: Johnson and Johnson – Key offerings
• Exhibit 138: Johnson and Johnson – Segment focus

• 12.9 Medtronic Plc 
• Exhibit 139: Medtronic Plc – Overview
• Exhibit 140: Medtronic Plc – Business segments
• Exhibit 141: Medtronic Plc – Key news
• Exhibit 142: Medtronic Plc – Key offerings
• Exhibit 143: Medtronic Plc – Segment focus

• 12.10 Nuvasive Inc 
• Exhibit 144: Nuvasive Inc – Overview
• Exhibit 145: Nuvasive Inc – Business segments
• Exhibit 146: Nuvasive Inc – Key news
• Exhibit 147: Nuvasive Inc – Key offerings
• Exhibit 148: Nuvasive Inc – Segment focus

• 12.11 Orthofix Medical Inc. 
• Exhibit 149: Orthofix Medical Inc. – Overview
• Exhibit 150: Orthofix Medical Inc. – Business segments
• Exhibit 151: Orthofix Medical Inc. – Key news
• Exhibit 152: Orthofix Medical Inc. – Key offerings
• Exhibit 153: Orthofix Medical Inc. – Segment focus

• 12.12 OrthoPediatrics Corp. 
• Exhibit 154: OrthoPediatrics Corp. – Overview
• Exhibit 155: OrthoPediatrics Corp. – Business segments
• Exhibit 156: OrthoPediatrics Corp. – Key news
• Exhibit 157: OrthoPediatrics Corp. – Key offerings
• Exhibit 158: OrthoPediatrics Corp. – Segment focus

• 12.13 ROYAL BIOLOGICS 
• Exhibit 159: ROYAL BIOLOGICS – Overview
• Exhibit 160: ROYAL BIOLOGICS – Product / Service
• Exhibit 161: ROYAL BIOLOGICS – Key offerings

• 12.14 RTI Surgical Inc. 
• Exhibit 162: RTI Surgical Inc. – Overview
• Exhibit 163: RTI Surgical Inc. – Product / Service
• Exhibit 164: RTI Surgical Inc. – Key offerings

• 12.15 SeaSpine Holdings Corp. 
• Exhibit 165: SeaSpine Holdings Corp. – Overview
• Exhibit 166: SeaSpine Holdings Corp. – Business segments
• Exhibit 167: SeaSpine Holdings Corp. – Key offerings
• Exhibit 168: SeaSpine Holdings Corp. – Segment focus

• 12.16 Smith and Nephew plc 
• Exhibit 169: Smith and Nephew plc – Overview
• Exhibit 170: Smith and Nephew plc – Business segments
• Exhibit 171: Smith and Nephew plc – Key news
• Exhibit 172: Smith and Nephew plc – Key offerings
• Exhibit 173: Smith and Nephew plc – Segment focus

• 12.17 Stryker Corp. 
• Exhibit 174: Stryker Corp. – Overview
• Exhibit 175: Stryker Corp. – Business segments
• Exhibit 176: Stryker Corp. – Key news
• Exhibit 177: Stryker Corp. – Key offerings
• Exhibit 178: Stryker Corp. – Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 181: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources

• 13.5 List of abbreviations 
• Exhibit 185: List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base comprises enterprises of all sizes, including over 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio